Komunikace s handicapovanými

prof. ThLic. MUDr. Květoslav Šipr, CSc.

Dermatol. praxi. 2015;9(2)  

Current options in the treatment of chronic venous insufficiency

MUDr.Ivo Hofírek

Dermatol. praxi. 2015;9(2):54-57  

This article presents current views on chronic venous insufficiency (CVI). It deals with opinions on the diagnosis of the disease. It assesses the standard and intervention therapy. For the treatment of CVI are important duplex sonography, compression therapy and perforator ligation and stripping saphenous vein.

What sunscreen and how strong should be applied when travelling?

MUDr.Radek Litvik

Dermatol. praxi. 2015;9(2):58-62  

Photoprotection of human skin by means of sunscreens is traditionally centered around the prevention of acute (e.g. sunburn) and chronic (e. g. skin cancer and photoageing) skin damage that may result from exposure to ultraviolet rays (UVB and UVA). Sunscreen products provide efficient photoprotection throughout the entire ultraviolet spectrum.

Effect of LPG-endermotherapy on skin changes resulting from long-term treatment with glatiramer acetate

MUDr.Jana Földesová, MUDr.Vladimír Drvota, MUDr.Eva Meluzínová

Dermatol. praxi. 2015;9(2):63-66  

Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system (CNS). Early initiation of treatment can slow down the whole process. The article deals with local adverse effects at the injection site when using glatiramer acetate (GA) – Copaxone®, and, in particular, with interfering with the local response by means of the LPG-endermotherapy technique. It is a unique technology that was developed based on personal experience of the founder and author, Mr. Louis Paul Guitay (LPG). Endermotherapy is mechanical stimulation of sensitive tissue with a special lift head during which activation of fibroblasts...

Adalimumab - long-term safety and new indications in dermatology

MUDr.Veronika Slonková, Ph.D., prof.MUDr.Vladimír Vašků, CSc.

Dermatol. praxi. 2015;9(2):67-68  

Adalimumab is a recombinant human monoclonal antibody against tumour necrosis factor alfa (TNF-alfa). It is indicated for the treatment of moderate to severe chronic plaque psoriasis in adults in whom other systemic treatment is not efficacious or it is contraindicated or not tolerated. Now, based on REACH study, adalimumab is also indicated in the treatment of moderate to severe chronic plaque psoriasis of hands and/or feet. REACH study proved that treatment with adalimumab resulted in better quality of life because of reduced pain and nail improvement. Adalimumab is efficacious and safe drug for a long-term treatment of chronic plaque psoriasis.

Health aspects of antiperspirants

MUDr.Renata Kučerová, Ph.D.

Dermatol. praxi. 2015;9(2):70-72  

Antiperspirants as a common part of axillary hygiene significantly reduce sweat secretion by the apocrine glands, thus affecting body odour. In man, perspiration has major importance in terms of thermoregulation. The history of using axillary hygiene goes back a long time; however, the development of true antiperspirants, whose main active ingredients are aluminium or zirconium compounds, started in the early 20th century. In addition to the positive effect of reducing undesirable sweating and the associated risk of body malodour, antiperspirants can also affect human health in a negative way. An indirect negative effect is the effect of freons,...

Seborrheic dermatitis

MUDr.Martina Grycová

Dermatol. praxi. 2015;9(2):77-78  

Seborrheic dermatitis is a chronic relapsing inflammatory skin disorder which is a common and mild disease. However, it could result in negative social impact due to its signs and distribution. The article describes a severe seborrheic dermatitis case related to and induced by psychological stress.

Keloid scars

MUDr.Jaroslav Urbánek

Dermatol. praxi. 2015;9(2):84-85  

Keloid scars result from an abnormal wound healing. They represent the cosmetic problem with frequently considerable psychosocial impact. The paper briefly summarizes the basic informations about keloid scars and the contemporary treatment options.

Care of irritated skin in the summer: over-the-counter products

MUDr.Kateřina Fajkošová

Dermatol. praxi. 2015;9(2):79-82  

Irritant contact dermatitis is a term referring to inflammatory reactions occurring due to the action of toxic agents on the skin. It is encountered by everyone in their lifetime. In the acute course, it can often be managed with over-the-counter products, of which there is a vast variety available in the market. In the chronic course in particular, sensitization to many substances can occur, and an originally irritant dermatitis changes into an allergic one. The disease can be complicated by bacterial or viral infection. In such a case it should be taken care of by a dermatologist.

Naftitine in the management of dermatomycoses

doc.MUDr.Ivana Kuklová, CSc.

Dermatol. praxi. 2015;9(2):73-76  

Naftifine is a member of allylamine antimycotics that possesses only topical activity, has fungicidal mode of action, and is effective and safe in the management of superficial dermatomycoses. In vitro and in vivo bioavailability studies have demonstrated that naftifine penetrates the stratum corneum in sufficient concentration to inhibit the growth of dermatophytes. Rapid onset of clinical activity and favorable data on sustained clearance of infection have been documented with naftifine.

XVIII. olomoucká dermatologická konference, 20. března 2015 - abstrakta

Dermatol. praxi. 2015;9(2):86-90